Medicare Enrolled
Dr. Sarabjit Singh, MD
Cardiovascular Disease · Bakersfield, CA
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singh
Dr. Sarabjit Singh is a cardiovascular disease specialist in Bakersfield, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 5,179 Medicare services across 3,228 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singh received a total of $6,489 from 29 pharmaceutical and/or device companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in CA
$6,489 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,179
Medicare services
Top 18% in CA for cardiovascular disease
3,228
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~259 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,792 | $91 | $176 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
620 | $11 | $73 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
548 | $44 | $85 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
334 | $154 | $848 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
329 | $4 | $48 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
320 | $172 | $222 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
182 | $51 | $232 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
161 | $364 | $1,485 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
160 | $1 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $120 | $345 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
84 | $161 | $500 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
75 | $57 | $347 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
74 | $42 | $101 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
64 | $63 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
47 | $137 | $361 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
45 | $28 | $100 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
42 | $17 | $50 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
37 | $94 | $197 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
33 | $40 | $98 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
26 | $35 | $62 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
23 | $21 | $100 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $129 | $251 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
22 | $16 | $37 |
| Cardiac catheterization | 16 | $213 | $2,073 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
13 | $204 | $600 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
11 | $6 | $15 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.3% high complexity
25.5% medium
62.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,489
Total received (2018-2024)
Avg $927/year across 7 years
Top 35% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
278
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,489 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,093
2023
$1,456
2022
$1,165
2021
$726
2020
$457
2019
$991
2018
$601
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$298
Silk Road Medical, Inc.
$135
PFIZER INC.
$135
Merck Sharp & Dohme LLC
$109
E.R. Squibb & Sons, L.L.C.
$89
Novartis Pharmaceuticals Corporation
$89
Medtronic, Inc.
$77
Amgen Inc.
$47
AstraZeneca Pharmaceuticals LP
$41
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$31
Kiniksa Pharmaceuticals International, plc
$26
Janssen Pharmaceuticals, Inc
$15
Top 3 companies account for 52.1% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$726
ABIOMED
$676
Novartis Pharmaceuticals Corporation
$633
AstraZeneca Pharmaceuticals LP
$604
Merck Sharp & Dohme LLC
$592
PFIZER INC.
$453
E.R. Squibb & Sons, L.L.C.
$352
Amgen Inc.
$351
Medtronic, Inc.
$324
Janssen Pharmaceuticals, Inc
$245
Medtronic Vascular, Inc.
$223
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$213
CVRx, Inc.
$142
Silk Road Medical, Inc.
$135
Bayer HealthCare Pharmaceuticals Inc.
$113
SANOFI-AVENTIS U.S. LLC
$110
Merck Sharp & Dohme Corporation
$103
Boston Scientific Corporation
$95
Edwards Lifesciences Corporation
$86
W. L. Gore & Associates, Inc.
$62
Amarin Pharma Inc.
$61
Esperion Therapeutics, Inc.
$37
SCPHARMACEUTICALS INC.
$36
Kiniksa Pharmaceuticals International, plc
$26
Kiniksa Pharmaceuticals, Ltd.
$21
iRhythm Technologies, Inc.
$19
Osprey Medical Inc
$18
Lilly USA, LLC
$17
Cardiovascular Systems Inc.
$16
Top 3 companies account for 31.4% of all-time payments
Associated products mentioned in payments ›
3F · AVALUS · Advisa · Arcalyst · Attain · BRILINTA · Barostim Neo System · CARDIOSIGHT READER · CHANTIX · Cobalt · CoreValve Evolut · Corlanor · Diamondback Peripheral · DyeVert · ELIQUIS · ENROUTE Transcarotid Neuroprotection System · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FUROSCIX · GORE EXCLUDER AAA Endoprosthesis · Impella · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LifeVest · MICRA · MYCARELINK · NEXLETOL · PRADAXA · PRALUENT · Repatha · Reveal LINQ · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN Access System · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
30
Per 100K population
3.3
County median income
$67,660
Nearest hospital
BAKERSFIELD MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Singh is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Singh performed 1,792 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $6,489 from 29 companies across 278 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other cardiologists in Bakersfield?
Dr. Singh's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Bakersfield
Browse cardiologists in Bakersfield ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology